Clinical Trials Browser

Anxiety Disorders, Nausea, Pain, Parasomnias

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT02991456 2023-07-11

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

Phase 2 Completed

48 enrolled 25 charts

CNS

Glioma, Nausea, Vomiting

NCT04669132 2022-02-23

OLNEPA

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms, Nausea

NCT03862144 2019-03-05

GIM15-NEPA

Phase 2 Completed

150 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT01534637 2018-08-15

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Phase 2 Completed

22 enrolled 9 charts

Gastrointestinal

Bile Duct Neoplasms, Nausea, Pancreatic Neoplasms, Vomiting

NCT01450826 2018-06-26

Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide

Phase 2 Completed

136 enrolled 10 charts

CNS

Glioma, Nausea, Vomiting

NCT00381862 2017-06-12

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Phase 2 Completed

54 enrolled 7 charts

Gastrointestinal

Colonic Neoplasms, Nausea, Rectal Neoplasms, Vomiting, Colorectal Neoplasms

NCT00600353 2017-03-09

Multi-day Doses in Prevention of Nausea and Emesis

Phase 2 Completed

20 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Nausea, Neoplasms

NCT00064272 2016-10-21

IRB 2003-551

Phase 2 Completed

180 enrolled

Nausea, Vomiting

NCT02787707 2016-06-03

Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting

Phase 2 Completed

69 enrolled

Breast

Breast Neoplasms, Nausea, Vomiting

NCT00003817 2015-10-15

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Phase 2 Completed

700 enrolled

Nausea, Vomiting

NCT00954941 2015-06-25

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

Phase 2 Completed

100 enrolled 7 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Nausea, Vomiting, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT00212602 2012-06-14

ONO-7436 Phase II Study in Japan

Phase 2 Completed

420 enrolled

Nausea, Neoplasms, Vomiting

NCT00004895 2012-06-06

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Phase 2 Completed

GastrointestinalGynecologicOtherSarcoma

Carcinoma, Ovarian Epithelial, Bile Duct Neoplasms, Colonic Neoplasms, Constipation, Intestinal Obstruction, Nausea, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Vomiting, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT00169572 2010-05-10

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Phase 2 Completed

492 enrolled

Nausea, Vomiting

Clinical Trials

CAFCARS

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide

OLNEPA

GIM15-NEPA

Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer

Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Multi-day Doses in Prevention of Nausea and Emesis

IRB 2003-551

Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting

Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy

Ondansetron Versus Aprepitant Plus Ondansetron for Emesis

ONO-7436 Phase II Study in Japan

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy